Chemotherapy dose standardisation: Key therapeutic topic [KTT22]
This document summarises the evidence-base on chemotherapy dose standardisation. It is a key therapeutic topic which has been identified to support medicines optimisation. It is not formal NICE guidance.
https://www.nice.org.uk/advice/ktt22
Thanks to all the BOPA members who have contributed to the implementation support documents.
Join the National Prostate Cancer Audit (NPCA) and National Cancer Audit Collaborating Centre (NATCAN) for our next quality improvement webinar on Thursday 19th March 2026 at 09:00 am. Bringing together data managers, clinicians, allied healthcare professionals, and other relevant stakeholders,…
We’re delighted to share that the BOPA abstracts presented at the 28th Annual BOPA Conference have now been published in the Journal of Oncology Pharmacy Practice. Huge congratulations to everyone…
BOPA welcomes the National Cancer Plan and highlights the essential role of cancer pharmacy professionals in delivering world‑class cancer care – The National Cancer Plan for England: delivering world class…
Open Letter to UK Pharmacists, Pharmacy Technicians and Pharmacy Trainees and Students Through an open letter published on its website, the UK Pharmacy Professional Leadership Advisory Board is inviting…
The 29th BOPA Annual Conference in 2026 will be held at the ICC London Olympia on 2-4 October 2026.
Check out the latest information here: Latest Conference 2026 – BOPA
Everything you need to know
